Top Markets
#1 Palladium Network Palladium Network +27.94%
#2 MarsCoin MarsCoin +25.78%
#3 Hive Hive +25.60%
#4 Siren Siren +24.48%
#5 BankrCoin BankrCoin +20.74%
#6 Ankr Network Ankr Network +17.93%
#7 StonkBroker StonkBroker +16.54%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.19%
#9 Status Status +11.03%
#10 Provenance Blockchain Provenance Blockchain +8.81%
Coin of the day
Palladium Network Palladium Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Rang in Aktien #18384
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Aktienkurs
$0.28269336
Marktkapitalisierung
$201.23M
Veränderung (1 Tag)
0.34%
Veränderung (1 Jahr)
-9.58%
Land
TW
Handel TaiGen Biopharmaceuticals Holdings Limited (4157)

Kategorie

Healthcare
Preis 4157 mit Marktkapitalisierung von B
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
4157
$0.28269336
Marktkapitalisierung von TaiGen Biopharmaceuticals Holdings Limited(4157)
Marktkapitalisierung: $201.23M
Mit Stand September 2026 hat TaiGen Biopharmaceuticals Holdings Limited eine Marktkapitalisierung von $201.23M. Das macht TaiGen Biopharmaceuticals Holdings Limited laut unseren Daten zum 18384th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von TaiGen Biopharmaceuticals Holdings Limited von 2013 bis 2026
4157 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 4157 Vermögenswert B Marktkapitalisierung von B Ergebnisse
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$7,620.17 $201.23M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.424T +2,695,458.76%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$6,709.27 $201.23M
Apple Inc. Apple Inc.
AAPL
$4.776T +2,373,238.91%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$5,692.08 $201.23M
Alphabet Inc. Alphabet Inc.
GOOG
$4.052T +2,013,416.26%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$5,185.25 $201.23M
Microsoft Corporation Microsoft Corporation
MSFT
$3.691T +1,834,132.11%
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited
$3,855.17 $201.23M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.744T +1,363,629.88%